Clinical Trial Update: A Comparison of Serum and Urine N-telopeptide Marker

View source ↗

Summary

The Cleveland Clinic-sponsored trial comparing serum and urine N-telopeptide markers in osteoporosis and bone fractures has completed and posted the results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Fractures
• Osteoporosis

Snippet

Sponsor: The Cleveland Clinic | Conditions: Osteoporosis, Fractures, Bone | Status: COMPLETED | Results posted: 2024-09-24